These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7841636)

  • 1. Substance use in pregnancy: do we care?
    Boer K; Smit BJ; van Huis AM; Hogerzeil HV
    Acta Paediatr Suppl; 1994 Nov; 404():65-71. PubMed ID: 7841636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retrospective analysis of neonatal data in a monocentric cohort of 170 newborns of polydrug-using mothers, Île-de-France, 1999-2008].
    Lejeune C; Genest L; Miossec E; Simonpoli AM; Simmat-Durand L
    Arch Pediatr; 2013 Feb; 20(2):146-55. PubMed ID: 23266175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of substance abuse during pregnancy and infant outcome.
    Little BB; Snell LM; Van Beveren TT; Crowell RB; Trayler S; Johnston WL
    Am J Perinatol; 2003 Jul; 20(5):255-62. PubMed ID: 13680509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance abuse during pregnancy: effect on pregnancy outcomes.
    Pinto SM; Dodd S; Walkinshaw SA; Siney C; Kakkar P; Mousa HA
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):137-41. PubMed ID: 20227162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perinatal outcome of children born to women with substance dependence detoxified in residential treatment during pregnancy.
    Haabrekke KJ; Slinning K; Walhovd KB; Wentzel-Larsen T; Moe V
    J Addict Dis; 2014; 33(2):114-23. PubMed ID: 24717065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant.
    Thaithumyanon P; Limpongsanurak S; Praisuwanna P; Punnahitanon S
    J Med Assoc Thai; 2005 Nov; 88(11):1506-13. PubMed ID: 16471094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes.
    Armstrong MA; Gonzales Osejo V; Lieberman L; Carpenter DM; Pantoja PM; Escobar GJ
    J Perinatol; 2003 Jan; 23(1):3-9. PubMed ID: 12556919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detoxification from opiate drugs during pregnancy.
    Bell J; Towers CV; Hennessy MD; Heitzman C; Smith B; Chattin K
    Am J Obstet Gynecol; 2016 Sep; 215(3):374.e1-6. PubMed ID: 26996987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of adverse obstetric outcomes and maternity hospitalization among heroin-exposed and methadone-treated women in Taiwan.
    Chen CY; Lien YT; Yeh HH; Su LW; Ho IK
    Int J Drug Policy; 2015 Feb; 26(2):191-8. PubMed ID: 25171908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birth to age 7 growth of children prenatally exposed to drugs: a prospective cohort study.
    Covington CY; Nordstrom-Klee B; Ager J; Sokol R; Delaney-Black V
    Neurotoxicol Teratol; 2002; 24(4):489-96. PubMed ID: 12127894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine use in pregnancy in Amsterdam.
    Smit BJ; Boer K; van Huis AM; Lie-A-Ling IS; Schmidt SC
    Acta Paediatr Suppl; 1994 Nov; 404():32-5. PubMed ID: 7531040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of prenatal substance use disorders with pregnancy and birth outcomes following bariatric surgery.
    Kim J; Davidson L; Hunt S; Richards N; Adams T
    Int J Obes (Lond); 2022 Jan; 46(1):107-112. PubMed ID: 34508153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and neonatal outcomes following methadone substitution during pregnancy.
    Greig E; Ash A; Douiri A
    Arch Gynecol Obstet; 2012 Oct; 286(4):843-51. PubMed ID: 22584603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive treatment program for pregnant substance users in a family medicine clinic.
    Ordean A; Kahan M
    Can Fam Physician; 2011 Nov; 57(11):e430-5. PubMed ID: 22084472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hepatitis C in pregnancy.
    Berkley EM; Leslie KK; Arora S; Qualls C; Dunkelberg JC
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):304-10. PubMed ID: 18669727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of prenatal substance use and birth weight during outpatient treatment.
    Laken MP; McComish JF; Ager J
    J Subst Abuse Treat; 1997; 14(4):359-66. PubMed ID: 9368212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
    Vega J; Sáez G; Smith M; Agurto M; Morris NM
    Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in very low birth weight deliveries and perinatal mortality in a specialized, multidisciplinary twin clinic.
    Ellings JM; Newman RB; Hulsey TC; Bivins HA; Keenan A
    Obstet Gynecol; 1993 Mar; 81(3):387-91. PubMed ID: 8437792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.